Fundación Epic

This study tests a new drug-coated heart stent (VIVO ISAR) against a standard one (XIENCE Skypoint) in 40 people with coronary artery disease. Each patient receives both stents in different blocked arteries, and a special camera checks healing after one month. The goal is to see …

This study is a registry that follows 400 adults with coronary artery disease who received a drug-coated stent called ihtDEStiny during a standard procedure to open blocked heart arteries. The goal is to track how well the stent works over time, including rates of heart attack, r…

This study looks at whether it is safe for people with narrowed heart valves to be discharged just 24 hours after a minimally invasive valve replacement (TAVI). Researchers will track 585 patients for complications like stroke, heart attack, or need for a pacemaker. The goal is t…

This study looks at how doctors in Spain use blood-thinning drugs during heart procedures called PCI (stent placement). Researchers will track 717 patients to see which drugs are used and how well they work in everyday practice. The goal is to understand short-term safety and eff…

This study compares two imaging techniques, OCT and IVUS, used to evaluate blockages in a major heart artery. Researchers will measure how well these methods agree on the severity of narrowing in 153 adults with intermediate blockages. The goal is to improve future treatment deci…